Trial intelligence / Profile preview

Sinovac Varicella Vaccine Phase 4

NCT05470855Phase 4Unknown

Sponsor
Sinovac Biotech Ltd.
Start
Jul 2022
Primary completion
Nov 2022
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of varicella vaccine live in varicella (VZV), sponsored by Sinovac Biotech Ltd.. Status: unknown.

02

Drugs

varicella vaccine live
03

Conditions

varicella (VZV)

Beyond the preview

Go deeper on NCT05470855.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05470855.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call